Response to the Letter to the Editor by Shinji Matsunaga “Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials”-Reference-Cited by-同舟云学术

Response to the Letter to the Editor by Shinji Matsunaga “Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials”

Published:2016-11 Issue:11 Volume:17 Page:1063
ISSN:1525-8610
Container-title:Journal of the American Medical Directors Association
language:en
Short-container-title:Journal of the American Medical Directors Association

Author:

Tsoi Kelvin K.F.,Chan Joyce Y.C.,Wong Michael P.F.,Kwok Timothy C.Y.

Publisher

Elsevier BV

Subject

Health Policy,General Medicine,General Nursing,Geriatrics and Gerontology

Reference13 articles.

1. Combination therapy showed limited superiority over monotherapy for Alzheimer disease: A meta-analysis of 14 randomized trials;Tsoi;J Am Med Dir Assoc,2016

2. ECDEU Assessment Manual for Psychopharmacology;Guy,1976

3. The Alzheimer's Disease Cooperative Study: Validity and reliability of the Alzheimer's Disease Cooperative Study–Clinical Global Impression of Change;Schneider;Alzheimer Dis Assoc Disord,1997

4. The effects of combined treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area;Araki;Int J Geriatr Psychiatry,2014

5. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: A subgroup analysis in patients already taking or not taking concomitant memantine;Doody;Dement Geriatr Cogn Disord,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Psychiatric Symptoms in Dementia;Neurologic Clinics;2023-02

2. Effects of Pharmacological Treatments in Alzheimer’s Disease: Permutation Entropy-Based EEG Complexity Study;Brain Topography;2022-11-18

3. Potentiation of cognitive enhancer effects of Alzheimer’s disease medication memantine by alpha7 nicotinic acetylcholine receptor agonist PHA-543613 in the Morris water maze task;Psychopharmacology;2021-08-13

4. Cognitive symptoms of Alzheimer’s disease: clinical management and prevention;BMJ;2019-12-06

5. Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury;PLOS ONE;2019-10-03